Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702344 | Surgical Oncology | 2017 | 10 Pages |
Abstract
On the basis of retrospective data this study shows that PD with PSMVR is associated with a higher R1 rate, lower 5-year survival and is not cost-effective. It appears that PD with PSMVR can only be justified if R0 resection can be achieved. The continuing challenge is accurate selection of these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Richard Bell, Braden Te Ao, Natasha Ironside, Adam Bartlett, John A. Windsor, Sanjay Pandanaboyana,